obecabtagene autoleucel Aucatzyl

Selected indexed studies

• Obecabtagene Autoleucel: First Approval. (Mol Diagn Ther, 2025) [PMID:39888581]
• Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells. (Transplant Cell Ther, 2025) [PMID:39954962]
• In brief: Obecabtagene autoleucel (Aucatzyl) - another CAR-T cell immunotherapy for ALL. (Med Lett Drugs Ther, 2024) [PMID:39762192]

_Worker-drafted node — pending editorial review._